Postoperative Urinary Retention.
| Autor: | McDermott CD; From the Mount Sinai Hospital, University of Toronto, Toronto, Canada., Tunitsky-Bitton E; Hartford Hospital, Hartford, CT; University of Connecticut School of Medicine, Farmington, CT., Dueñas-Garcia OF; West Virginia University, WVU Medicine, Morgantown, WV., Willis-Gray MG; University of North Carolina at Chapel Hill, Chapel Hill, NC., Cadish LA; Providence Saint John's Health Center, Santa Monica, CA., Edenfield A; Medical University of South Carolina, Charleston, SC., Wang R; Penn Medicine Princeton Health, Princeton, NJ., Meriwether K; University of New Mexico, Albuquerque, NM., Mueller ER; Loyola University Chicago Stritch School of Medicine, Loyola University Medical Center, Maywood, IL. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Urogynecology (Philadelphia, Pa.) [Urogynecology (Phila)] 2023 Apr 01; Vol. 29 (4), pp. 381-396. |
| DOI: | 10.1097/SPV.0000000000001344 |
| Abstrakt: | Abstract: This clinical consensus statement on the management of postoperative (<6 weeks) urinary retention (POUR) reflects statements drafted by content experts from the American Urogynecologic Society's POUR writing group. The writing group used a modified Delphi process to evaluate statements developed from a structured literature search and assessed for consensus. After the definition of POUR was established, a total of 37 statements were assessed in the following 6 categories: (1) incidence of POUR, (2) medications, (3) patient factors, (4) surgical factors, (5) urodynamic testing, and (6) voiding trials. Of the 37 original statements, 34 reached consensus and 3 were omitted. Competing Interests: C.D.M. is a medical advisor for Szio, Inc, and COSM, Inc, and a speaker for Pfizer. These companies were not involved in any facet of this study. O.F.D.-G. is a consultant of Applied Medical and received a research grant from Merck, a biopharmaceutical company. These companies and organizations were not involved in any facet of this study. K.M. received royalties for Elsevier Publishing for book editing and is a consultant for RBI Medical, an executive board member of the Society of Gynecologic Surgeons (travel reimbursement), a nonpaid researcher for Cook MyoSure and Caldera Medical, and an editorial board member for the journals of Obstetrics and Gynecology and Urogynecology. These companies and organizations were not involved in any facet of this study. E.R.M. received an honorarium from UpToDate and research funding from the NIH, does legal consultation for Ethicon/Butler Snow, and is part of the research advisory board of Ferring. These companies were not involved in any facet of this study. The other authors have declared they have no conflicts of interest. (Copyright © 2023 American Urogynecologic Society. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|